Robert Vescio
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 0.5%
- Peptidase Inhibition and Analysis
- Bone health and treatments
- Viral-associated cancers and disorders
Papers in
- Hematology 106
- Multiple Myeloma Research and Treatments 103
- Oncology 67
- Cancer Treatment and Pharmacology 22
- Peptidase Inhibition and Analysis 18
- Bone health and treatments 12
- Viral-associated cancers and disorders 11
- Co-authors
- James R. Berenson (79 shared papers)Alan Lichtenstein (11 shared papers)Regina A. Swift (40 shared papers)Gary J. Schiller (12 shared papers)Yiping Tu (4 shared papers)Hank H. Yang (6 shared papers)Matthew B. Rettig (4 shared papers)Robert H. Collins (1 shared paper)
- Journals
- Blood (43 papers)Journal of Clinical Oncology (20 papers)British Journal of Haematology (9 papers)Leukemia (6 papers)Current Opinion in Hematology (4 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Robert Vescio
145 papers receiving 6.0k citations
Peers
Comparison fields: 5 of 102
- Hematology 2.9k
- Oncology 2.8k
- Genetics 510
- Immunology 816
- Molecular Biology 2.7k
Countries citing papers authored by Robert Vescio
This map shows the geographic impact of Robert Vescio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Vescio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Vescio more than expected).
Fields of papers citing papers by Robert Vescio
This network shows the impact of papers produced by Robert Vescio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Vescio. The network helps show where Robert Vescio may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Vescio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 470 | |
| 2 | 1997 | 405 | |
| 3 | The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents. | 2003 | 345 |
| 4 | 2002 | 324 | |
| 5 | 1995 | 251 | |
| 6 | 2000 | 241 | |
| 7 | 2012 | 222 | |
| 8 | 1995 | 218 | |
| 9 | 2014 | 210 | |
| 10 | BCL-X expression in multiple myeloma: possible indicator of chemoresistance. | 1998 | 203 |
| 11 | 2006 | 171 | |
| 12 | 1997 | 133 | |
| 13 | 1987 | 128 | |
| 14 | 2011 | 127 | |
| 15 | 2009 | 124 | |
| 16 | 2009 | 117 | |
| 17 | 1995 | 116 | |
| 18 | 1996 | 92 | |
| 19 | 1997 | 85 | |
| 20 | A phase I dose-ranging trial of monthly infusions of zoledronic acid for the treatment of osteolytic bone metastases. | 2001 | 84 |
About Robert Vescio
Robert Vescio is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Infectious Diseases, having authored 151 papers that have together received 6.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (103 papers), Protein Degradation and Inhibitors (36 papers), Cancer Treatment and Pharmacology (22 papers), Peptidase Inhibition and Analysis (18 papers), Bone health and treatments (12 papers), Viral-associated cancers and disorders (11 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers). The work is most often cited by research in Hematology (2.9k citations), Oncology (2.8k citations), Genetics (510 citations), Immunology (816 citations) and Molecular Biology (2.7k citations). Robert Vescio has collaborated with scholars based in United States, Germany and France. Frequent co-authors include James R. Berenson, Alan Lichtenstein, Regina A. Swift, Gary J. Schiller, Yiping Tu, Hank H. Yang, Matthew B. Rettig, Robert H. Collins, Daniel C. Douek and Richard A. Koup. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Leukemia and Current Opinion in Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.